Format

Send to

Choose Destination
Clin Genitourin Cancer. 2017 Aug;15(4):e727-e734. doi: 10.1016/j.clgc.2016.11.001. Epub 2016 Dec 1.

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.

Author information

1
Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ; Mayo Clinic Cancer Center, Phoenix, AZ; Center for Individualized Medicine, Mayo Clinic, Rochester, MN. Electronic address: bryce.alan@mayo.edu.
2
Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ; Mayo Clinic Cancer Center, Phoenix, AZ; Center for Individualized Medicine, Mayo Clinic, Rochester, MN.
3
Center for Individualized Medicine, Mayo Clinic, Rochester, MN.
4
Mayo Clinic Cancer Center, Phoenix, AZ.
5
Translational Genomics Research Institute, Phoenix, AZ.
6
Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ.
7
Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.
8
Mayo Clinic Cancer Center, Phoenix, AZ; Translational Genomics Research Institute, Phoenix, AZ.
9
Department of Radiology, Mayo Clinic, Scottsdale, AZ.
10
Department of Anatomic and Clinical Pathology, Mayo Clinic, Rochester, MN.
11
Department of Urology, Mayo Clinic, Phoenix, AZ.
12
Center for Individualized Medicine, Mayo Clinic, Rochester, MN; Mayo Clinic Cancer Center, Rochester, MN.

KEYWORDS:

EGFR; Exome; Genome; Transcriptome; Urethral adenocarcinoma

PMID:
28057415
DOI:
10.1016/j.clgc.2016.11.001
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center